Existing user? Sign in Start 7-day access →
Stocks · MANKIND · F&O

Mankind Pharma share price & delivery.

Last close · 19 Oct 2026
₹2,253.20 -0.98%
Sector: Pharma & healthcare · RS rating 45
1W-6.1%1M-2.0%3M-12.2%6M+6.0%1Y-7.6%
52-week range
₹1,909.70-14.7% from the high₹2,642.00
Open in TradingView ↗

Price, volume and delivery

Candles adjusted for splits and bonuses. In the lower panel, the grey bar is the day’s volume and the coloured bar is the part that was delivered; bright green marks big-buyer days (delivered shares 3× the stock’s normal or more, with a normal-or-higher delivery %).

Mankind Pharma stock DNA

Where Mankind Pharma sits among the 1,422 most traded NSE stocks, on a 0–100 scale: 0 is the lowest of all of them, 100 the highest. From the last year of daily data. The first row is the RS rating used on our relative strength ranking.

Relative strength (RS rating)12-month return, latest quarter counted twice
Weak
Strong
45/100
Volatility27% a year
Calm
Wild
9/100
Daily range2.4% high to low
Tight
Wide
12/100
Opening gaps10% of days gap 1%+
Rare
Often
6/100
Delivery56% of volume delivered
Traders
Holders
84/100
Liquidity₹86.2 Cr a day
Thin
Deep
85/100
1-year return-7.6%
Laggard
Leader
50/100
Gap-ups of 1%+ (1 year)1681% filled the same day
Gap-downs of 1%+933% filled the same day
Up days45%of the last 250 sessions
Streak2 downsessions in a row

How Mankind Pharma usually moves

Every session of the last year by size of move. The white line is the last session.

-5.0% to -4.5%: 2 days-4.5% to -4.0%: 1 days-4.0% to -3.5%: 2 days-3.5% to -3.0%: 4 days-3.0% to -2.5%: 6 days-2.5% to -2.0%: 7 days-2.0% to -1.5%: 20 days-1.5% to -1.0%: 22 days-1.0% to -0.5%: 35 days-0.5% to +0.0%: 38 days+0.0% to +0.5%: 25 days+0.5% to +1.0%: 28 days+1.0% to +1.5%: 19 days+1.5% to +2.0%: 16 days+2.0% to +2.5%: 9 days+2.5% to +3.0%: 4 days+3.0% to +3.5%: 5 days+3.5% to +4.0%: 1 days+4.0% to +4.5%: 1 days+4.5% to +5.0%: 2 days+5.0% to +5.5%: 1 days+5.5% to +6.0%: 2 days-6%-4%-2%+0%+2%+4%+6%Dashed lines: a normal day, ±1.7%Last session -0.98%

Best day 21 Sep 2026 (+5.96%), worst 19 Mar 2026 (-4.86%).

Mankind Pharma vs NIFTY 50, one year

Both start at 100. The shaded gap is how far Mankind Pharma is ahead of or behind the market.

100Dec 25Mar 26Jun 26Sep 26Mankind Pharma -7.0%NIFTY 50 -8.6%

Peers in Pharma & healthcare

The most traded stocks in the same sector. All Pharma & healthcare stocks and the sector’s trend →

Divi's Labs+38.50% 1YRS 88Apollo Hospitals-0.76% 1YRS 52Laurus Labs+135.66% 1YRS 97Sun Pharma+5.36% 1YRS 56Dr Reddy's+0.42% 1YRS 61Max Healthcare-28.54% 1YRS 14Torrent Pharma+29.43% 1YRS 72Lupin+0.10% 1YRS 42

Delivery and big-buyer days

Delivered shares change owners for real; intraday trades don’t. Days when delivery jumps far above normal often mean large investors were buying or selling.

Delivery, last session60%7.36 L shares
Average, 60 sessions56%1-year median 56%
Big-buyer days, 1 year15delivery 3× normal or more

Delivery calendar, last 12 months

Each square is a session. The brighter the green, the more shares were delivered compared with Mankind Pharma’s normal. Hover or tap a square for the day.

MWFNovDecJanFebMarAprMayJunJulAugSepOct
Hover a square
QuietBelow normalNormalHighBig-buyer day

Latest big-buyer days

What the price did on the day and five sessions later. Past moves only.

DateDeliveredvs normalDelivery %Day5 days later
19 Oct 20267.36 L3.5×60%-0.98%–
30 Sep 20267.74 L4.0×59%-1.62%-4.94%
16 Sep 20264.92 L3.2×76%-1.51%+9.75%
17 Aug 20265.99 L3.7×74%-1.83%-0.27%
12 Aug 20265.39 L3.3×71%+0.33%-1.61%
31 Jul 202610.95 L5.9×46%-4.13%-0.55%
29 May 202615.66 L5.4×67%-1.85%-1.66%
21 May 20268.77 L3.1×48%-2.70%-5.51%

Mankind Pharma timeline

Everything that happened to Mankind Pharma, newest first: deals, promoter filings, results, big-buyer days, new highs and big moves.

  • October 2026
  • 26 Oct
    Board meeting: Financial ResultsTo consider and approve the financial results for the period ended September 30, 2026
  • 19 Oct
    Big-buyer day: 7.36 L shares delivered, 3.5× normal60% of the day’s volume was delivered; the price closed -0.98%.
  • September 2026
  • 30 Sep
    Big-buyer day: 7.74 L shares delivered, 4.0× normal59% of the day’s volume was delivered; the price closed -1.62%.
  • 21 Sep
    Jumped 6.0% in one sessionClosed at ₹2,437.80, about 3.5× a normal day’s move.
  • 16 Sep
    Big-buyer day: 4.92 L shares delivered, 3.2× normal76% of the day’s volume was delivered; the price closed -1.51%.
  • August 2026
  • 17 Aug
    Big-buyer day: 5.99 L shares delivered, 3.7× normal74% of the day’s volume was delivered; the price closed -1.83%.
  • 12 Aug
    Big-buyer day: 5.39 L shares delivered, 3.3× normal71% of the day’s volume was delivered; the price closed +0.33%.
  • July 2026
  • 31 Jul
    Big-buyer day: 10.95 L shares delivered, 5.9× normal46% of the day’s volume was delivered; the price closed -4.13%.
  • 22 Jul
    Q1 FY27 results: -1.35% on the dayPublished 21 Jul, 17:42 (after the close); opening gap -0.60%.
  • June 2026
  • 22 Jun
    Jumped 5.1% in one sessionClosed at ₹2,538.30, about 3.0× a normal day’s move.
  • May 2026
  • 29 May
    Big-buyer day: 15.66 L shares delivered, 5.4× normal67% of the day’s volume was delivered; the price closed -1.85%.
  • 21 May
    Big-buyer day: 8.77 L shares delivered, 3.1× normal48% of the day’s volume was delivered; the price closed -2.70%.
  • April 2026
  • 21 Apr
    Q4 FY26 results: +2.61% on the dayPublished 21 Apr, 11:07 (during market hours); opening gap +0.28%.
  • March 2026
  • 20 Mar
    Big-buyer day: 6.04 L shares delivered, 3.2× normal51% of the day’s volume was delivered; the price closed -0.04%.
  • 13 Mar
    Big-buyer day: 6.09 L shares delivered, 3.6× normal76% of the day’s volume was delivered; the price closed -3.13%.
  • 10 Mar
    Big-buyer day: 5.19 L shares delivered, 3.1× normal50% of the day’s volume was delivered; the price closed +3.44%.
  • February 2026
  • 26 Feb
    Jumped 5.8% in one sessionClosed at ₹2,279.70, about 3.4× a normal day’s move.
  • 19 Feb
    Big-buyer day: 5.18 L shares delivered, 3.0× normal70% of the day’s volume was delivered; the price closed -1.74%.
  • January 2026
  • 21 Jan
    Q3 FY26 results: -1.19% on the dayPublished 20 Jan, 17:07 (after the close); opening gap +0.00%.
  • October 2025
  • 16 Oct
    Q2 FY26 results: +0.39% on the dayPublished 15 Oct, 19:09 (after the close); opening gap +0.46%.
  • August 2025
  • 8 Aug
    Interim Dividend - Re 1 Per ShareEx-date: buy before this day to be entitled. From NSE’s corporate actions.
  • July 2025
  • 23 Jul
    Q1 FY26 results: -2.68% on the dayPublished 22 Jul, 18:44 (after the close); opening gap +0.16%.
  • April 2025
  • 29 Apr
    Q4 FY25 results: -0.14% on the dayPublished 29 Apr, 12:20 (during market hours); opening gap +0.00%.
  • January 2025
  • 24 Jan
    Q3 FY25 results: -4.86% on the dayPublished 24 Jan, 12:39 (during market hours); opening gap -2.85%.
  • November 2024
  • 6 Nov
    Q2 FY25 results: +1.27% on the dayPublished 5 Nov, 21:48 (after the close); opening gap +5.89%.

F&O snapshot

Near-month future and options for 19 Oct 2026. OI build-up for all stocks →

Futures₹2,261.60-0.95% on the day
Open interest37.04 L+1.17% on the day
Build-upShort Buildupprice and OI together
PCR0.47all expiries 0.48
Max pain₹2,3602026-10-27 expiry
Market-wide limit used20%ban at 95%

Futures price and open interest

Near-month futures and total futures open interest since May 2025. Rising OI with a rising price is fresh buying; with a falling price, fresh selling.

Last 20 sessions
Long build-up Short build-up Short covering Long unwinding

PCR and max pain history

Biggest open interest for the 27 Oct expiry: calls at 2,600 (often read as resistance), puts at 2,300 (often read as support).

PCR for all stocks → · Max pain record → · OI build-up & futures screener →

Results-day moves

How Mankind Pharma moved on each quarterly results day. Next board meeting: 26 Oct 2026. Every result since 2023 →

Typical move±1.9%last 12 results
vs a normal day1.9×bigger than usual
Closed higher50%of 14 results
+5%-5%+10%-10%Q4 FY23: +2.60% on 1 Jun 2023+2.6Q4 FY23Q1 FY24: +9.10% on 3 Aug 2023+9.1Q2 FY24: +0.12% on 1 Nov 2023+0.1Q2 FY24Q3 FY24: +2.32% on 1 Feb 2024+2.3Q4 FY24: -4.48% on 16 May 2024-4.5Q4 FY24Q1 FY25: -1.15% on 1 Aug 2024-1.2Q2 FY25: +1.27% on 6 Nov 2024+1.3Q2 FY25Q3 FY25: -4.86% on 24 Jan 2025-4.9Q4 FY25: -0.14% on 29 Apr 2025-0.1Q4 FY25Q1 FY26: -2.68% on 23 Jul 2025-2.7Q2 FY26: +0.39% on 16 Oct 2025+0.4Q2 FY26Q3 FY26: -1.19% on 21 Jan 2026-1.2Q4 FY26: +2.61% on 21 Apr 2026+2.6Q4 FY26Q1 FY27: -1.35% on 22 Jul 2026-1.3

Best and worst months

Average return in each calendar month since 2023. Full share price history →

Jan: average -5.96%, higher in 33% of years-6.0JanFeb: average +2.22%, higher in 67% of years+2.2FebMar: average +0.94%, higher in 67% of years+0.9MarApr: average +5.48%, higher in 100% of years+5.5AprMay: average -1.22%, higher in 67% of years-1.2MayJun: average +6.54%, higher in 50% of years+6.5JunJul: average +1.26%, higher in 50% of years+1.3JulAug: average +5.09%, higher in 50% of years+5.1AugSep: average +0.74%, higher in 50% of years+0.7SepOct: average +0.23%, higher in 33% of years+0.2OctNov: average -0.20%, higher in 33% of years-0.2NovDec: average +4.84%, higher in 67% of years+4.8Dec

My notes on Mankind Pharma

Private: saved only in this browser, never sent to us.

Questions

What is the 52-week high and low of Mankind Pharma?
Over the last 52 weeks, Mankind Pharma (MANKIND) traded between ₹1,909.70 and ₹2,642.00 (adjusted for splits and bonuses). The last close of ₹2,253.20 on 19 Oct 2026 is 14.7% below the high.
What is the delivery percentage of Mankind Pharma?
On 19 Oct 2026, 59.9% of Mankind Pharma’s traded shares were delivered. The 60-session average is 55.8%, and its median over the last year is 55.7%.
How volatile is Mankind Pharma?
Mankind Pharma’s daily moves over the last year add up to 27% annual volatility, higher than 9% of the 1,422 most traded NSE stocks. Its average day spans 2.4% from high to low.
How much does Mankind Pharma move on results day?
Over its last 12 quarterly results, Mankind Pharma moved ±1.9% on average on the reaction day, about 1.9× a normal day, and closed higher 50% of the time.

Data from NSE’s daily files, adjusted for splits and bonuses. Past behaviour is not a forecast. This is information, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.

Start 7-day access →How it works